The effects of canthaxanthin on JB/MS melanoma growth during retroviral pathogenesis induced by LP-BM5 murine leukemia virus.
Huang
D S
DS
Department of Family and Community Medicine University of Arizona, School of Medicine, Tucson 85724.
Watson
R R
RR
Chen
G J
GJ
Watzl
B
B
D000163:Acquired Immunodeficiency Syndrome; D000818:Animals; D001835:Body Weight; D016644:Canthaxanthin / Q000494:pharmacology*; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D005354:Fibrosarcoma / Q000150:complications / Q000276:immunology / Q000473:pathology; D006084:Graft Rejection / Q000187:drug effects; D007121:Immunocompetence / Q000187:drug effects*; D007371:Interferon-gamma / Q000378:metabolism; D009052:Leukemia Virus, Murine / Q000472:pathogenicity; D008546:Melanoma, Experimental / Q000150:complications* / Q000276:immunology / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL / Q000276:immunology; D016183:Murine Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000276:immunology / Q000473:pathology; D009368:Neoplasm Transplantation; D009929:Organ Size / Q000187:drug effects; D013154:Spleen / Q000473:pathology
D016207:Cytokines; D016644:Canthaxanthin; D007371:Interferon-gamma